629
Participants
Start Date
October 31, 2005
Primary Completion Date
March 31, 2006
Study Completion Date
June 30, 2008
rabeprazole sodium
Following a one week single-blind, placebo run-in phase, patients will receive rabeprazole 10 mg orally, once daily, for 14 days during the double-blind, randomized treatment phase. This will be followed by a one week single-blind placebo follow-up phase.
Placebo
Following a one week single-blind, placebo run-in phase, patients will receive placebo orally, once daily, for 14 days during the double-blind, randomized treatment phase. This will be followed by a one week single-blind placebo follow-up phase.
Jeffrey L. Newman, Vista
Eisai Inc.
INDUSTRY